Karen Rodriguez-Lorenc
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Cancer Research top 10%
- Genetics top 5%
- Molecular Biology
- Co-authors
- Yen‐Shen LuAditya BardiaDebu TripathyTetiana TaranNadia HarbeckFábio FrankeRafael Villanueva-VázquezSaúl Campos-Gómez
- Topics
- Advanced Breast Cancer Therapies (12 papers)Multiple Myeloma Research and Treatments (7 papers)Cancer Treatment and Pharmacology (6 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Karen Rodriguez-Lorenc
18 papers receiving 776 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Pulmonary and Respiratory Medicine 655
- Oncology 600
- Cancer Research 289
- Genetics 179
- Molecular Biology 84
Countries citing papers authored by Karen Rodriguez-Lorenc
This map shows the geographic impact of Karen Rodriguez-Lorenc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Rodriguez-Lorenc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Rodriguez-Lorenc more than expected).
Fields of papers citing papers by Karen Rodriguez-Lorenc
This network shows the impact of papers produced by Karen Rodriguez-Lorenc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Rodriguez-Lorenc. The network helps show where Karen Rodriguez-Lorenc may publish in the future.
Co-authorship network of co-authors of Karen Rodriguez-Lorenc
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Rodriguez-Lorenc. A scholar is included among the top collaborators of Karen Rodriguez-Lorenc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Rodriguez-Lorenc. Karen Rodriguez-Lorenc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 37 | |
| 6 | 8 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | 35 | |
| 13 | 33 | |
| 14 | 7 | |
| 15 | 5 | |
| 16 | 0 | |
| 17 | 21 | |
| 18 | Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancerbreakdown → | 591 |
| 19 | 37 |
About Karen Rodriguez-Lorenc
Karen Rodriguez-Lorenc is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 793 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Multiple Myeloma Research and Treatments (7 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Oncology (600 citations), Pulmonary and Respiratory Medicine (655 citations) and Cancer Research (289 citations). Karen Rodriguez-Lorenc has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Yen‐Shen Lu, Aditya Bardia, Debu Tripathy, Tetiana Taran, Nadia Harbeck, Fábio Franke, Rafael Villanueva-Vázquez, Saúl Campos-Gómez, Sara A. Hurvitz and Seock‐Ah Im. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.